AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development-10,546.28715,111.68622,490.578
Selling General and Administrative-6,536.0679,055.8858,957.441
Non Recurring----
Others----
Total Operating Expenses-17,082.35424,167.57131,448.019
Operating Income or Loss--17,082.354-24,167.571-31,448.019
Income from Continuing Operations
Total Other Income/Expenses Net--2,081.27559.853142.984
Earnings Before Interest and Taxes--17,082.354-24,167.571-31,448.019
Interest Expense----
Income Before Tax--19,163.629-24,107.718-31,305.035
Income Tax Expense----
Minority Interest--927.83-659.747
Net Income From Continuing Ops--19,163.629-24,107.718-31,305.035
Non-recurring Events
Discontinued Operations---9,606.199-7,743.737
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--19,163.629-32,010.242-38,125.415
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--19,163.629-32,010.242-38,125.415